Halberd
Pre-clinicalHalberd is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases, including COVID-19
Founded
2018
Focus
Infectious DiseaseNeuroscience
About
Halberd is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases, including COVID-19
Funding History
1Total raised: $1.5M
Seed$1.5MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2018
LocationJackson Center, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile